NEW YORK (GenomeWeb) – Laboratory Corporation of America reported today that its second quarter revenues increased around 3 percent year over year as the firm beat Wall Street estimates on the top and bottom line.

The Burlington, NC-based clinical lab giant reported revenues of $1.52 billion for the three months ended June 30, up from $1.47 billion for Q2 2013. Analysts, on average, had estimated revenues of $1.50 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature has retracted a 2002 epigenetics paper for image manipulation.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.